In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) closed at $8.63 in the last session, down -6.30% from day before closing price of $9.21. In other words, the price has decreased by -$6.30 from its previous closing price. On the day, 2.75 million shares were traded. AVAH stock price reached its highest trading level at $9.12 during the session, while it also had its lowest trading level at $7.8.
Ratios:
We take a closer look at AVAH’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 17.90 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.97. For the most recent quarter (mrq), Quick Ratio is recorded 1.09 and its Current Ratio is at 1.09.
On August 19, 2025, UBS Upgraded its rating to Neutral which previously was Sell but kept the price unchanged to $8.
Barclays Upgraded its Equal Weight to Overweight on August 19, 2025, while the target price for the stock was maintained at $9.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 24 ’25 when VIGANO PAUL R sold 1,500,000 shares for $9.00 per share. The transaction valued at 13,500,000 led to the insider holds 362,746 shares of the business.
J.H. Whitney Equity Partners V sold 1,251,909 shares of AVAH for $11,267,181 on Oct 24 ’25. The 10% Owner now owns 19,292,787 shares after completing the transaction at $9.00 per share. On Oct 24 ’25, another insider, WILLIAMS ROBERT M JR, who serves as the 10% Owner of the company, sold 1,500,000 shares for $9.00 each. As a result, the insider received 13,500,000 and left with 362,746 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVAH now has a Market Capitalization of 1802905216 and an Enterprise Value of 3314445568. As of this moment, Aveanna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 114.76, and their Forward P/E ratio for the next fiscal year is 15.50. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.95. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.83. Its current Enterprise Value per Revenue stands at 1.522 whereas that against EBITDA is 14.276.
Stock Price History:
The Beta on a monthly basis for AVAH is 2.04, which has changed by 0.57975984 over the last 52 weeks, in comparison to a change of 0.13355756 over the same period for the S&P500. Over the past 52 weeks, AVAH has reached a high of $10.32, while it has fallen to a 52-week low of $3.67. The 50-Day Moving Average of the stock is -2.38%, while the 200-Day Moving Average is calculated to be 44.67%.
Shares Statistics:
According to the various share statistics, AVAH traded on average about 1.70M shares per day over the past 3-months and 1446860 shares per day over the past 10 days. A total of 208.26M shares are outstanding, with a floating share count of 57.61M. Insiders hold about 72.42% of the company’s shares, while institutions hold 24.59% stake in the company. Shares short for AVAH as of 1760486400 were 5152755 with a Short Ratio of 3.03, compared to 1757894400 on 5083804. Therefore, it implies a Short% of Shares Outstanding of 5152755 and a Short% of Float of 7.5200000000000005.
Earnings Estimates
The stock of Aveanna Healthcare Holdings Inc (AVAH) is currently being evaluated by 6.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is $0.13, with high estimates of $0.15 and low estimates of $0.1.
Analysts are recommending an EPS of between $0.59 and $0.53 for the fiscal current year, implying an average EPS of $0.55. EPS for the following year is $0.57, with 9.0 analysts recommending between $0.68 and $0.37.
Revenue Estimates
According to 5 analysts,. The current quarter’s revenue is expected to be $617.91M. It ranges from a high estimate of $630M to a low estimate of $609.3M. As of. The current estimate, Aveanna Healthcare Holdings Inc’s year-ago sales were $519.87MFor the next quarter, 5 analysts are estimating revenue of $613.39M. There is a high estimate of $633M for the next quarter, whereas the lowest estimate is $594M.
A total of 5 analysts have provided revenue estimates for AVAH’s current fiscal year. The highest revenue estimate was $2.4B, while the lowest revenue estimate was $2.38B, resulting in an average revenue estimate of $2.39B. In the same quarter a year ago, actual revenue was $2.02BBased on 8 analysts’ estimates, the company’s revenue will be $2.53B in the next fiscal year. The high estimate is $2.59B and the low estimate is $2.43B.
